AntagomiR-192-5p-engineered exosomes encapsulated in MXene-modified GelMA hydrogel facilitated epithelization of burn wounds by targeting OLFM4.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40575328.
- Also identified by DOI 10.1016/j.bioactmat.2025.06.013 and PMC identifier 12198005.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Burn wound healing is a multifaceted process often complicated by excessive inflammation and impaired keratinocyte function, both of which are key factors contributing to delayed healing. In this study we screened the key miRNA regulating the epithelialization process under oxidative stress conditions through high-throughput sequencing. We identified that miR-192-5p was significantly upregulated in both oxidative stress models of keratinocytes and burn wound tissues, with detrimental effects on keratinocyte proliferation, migration, and apoptosis. Inhibition of miR-192-5p enhanced epidermal cell function by upregulating olfactomedin-4 (OLFM4), a key gene associated with cell proliferation, adhesion and migration. To optimize delivery and therapeutic efficacy, we engineered MSC-derived exosomes loaded with antagomiR-192-5p (ant-192; Final content: 2 nmol per wound; Loading efficiency: 35.22 ± 0.34 %) and then encapsulated into a composite hydrogel composed of GelMA and MXene (Ti<sub>3</sub>C<sub>2</sub>Tx) nanosheets, forming a multifunctional dressing (Exo-ant-192@M-Gel). It achieved sustained release of ant-192, delay its degradation, and exert anti-inflammatory properties, thus promoting epithelization and burn wound healing. This study offered a novel therapeutic approach for burn wound closure.